Paul Tudor Jones's AMGN Position Overview
Paul Tudor Jones (via Tudor Investment Corp Et Al) currently holds 119.8K shares of Amgen Inc. (AMGN) worth $33.82 M, representing 0.06% of the portfolio. First purchased in 2013-Q2, this long-term strategic position has been held for 50 quarters.
Based on 13F filings since 2013, Paul Tudor Jones has maintained a long-term strategic position in AMGN, representing a significant commitment to this investment thesis. Largest addition occurred in Q1 2024, adding 145.8K shares. Largest reduction occurred in Q4 2024, reducing 105.2K shares.
Analysis based on 13F filings available since 2013 Q2
Paul Tudor Jones's Amgen (AMGN) Holding Value Over Time
Track share changes against reported price movement
Quarterly Amgen (AMGN) Trades by Paul Tudor Jones
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2013 | +6,301 | Add 0.00% | 6,300 | $98.73 |
| Q3 2013 | -6,300 | Sold Out | 6,300 | $0.00 |
| Q4 2013 | +7,697 | New Buy | 7,697 | $114.07 |
| Q1 2014 | -3,712 | Reduce 48.23% | 3,985 | $123.46 |
| Q2 2014 | +5,028 | Add 126.17% | 9,013 | $118.38 |
| Q3 2014 | -5,713 | Reduce 63.39% | 3,300 | $140.61 |
| Q4 2014 | +1,300 | Add 39.39% | 4,600 | $159.35 |
| Q1 2015 | +5,265 | Add 114.46% | 9,865 | $159.86 |
| Q2 2015 | -1,890 | Reduce 19.16% | 7,975 | $153.48 |
| Q3 2015 | -1,175 | Reduce 14.73% | 6,800 | $138.38 |
| Q4 2015 | +1,229 | Add 18.07% | 8,029 | $162.29 |
| Q1 2016 | -2,729 | Reduce 33.99% | 5,300 | $150.00 |
| Q2 2016 | +369 | Add 6.96% | 5,669 | $152.23 |
| Q3 2016 | +15,664 | Add 276.31% | 21,333 | $166.83 |
| Q4 2016 | -17,633 | Reduce 82.66% | 3,700 | $146.22 |
| Q1 2017 | +4,132 | Add 111.68% | 7,832 | $164.07 |
| Q2 2017 | -7,832 | Sold Out | 7,832 | $0.00 |
| Q4 2017 | +9,716 | New Buy | 9,716 | $173.94 |
| Q1 2018 | +15,538 | Add 159.92% | 25,254 | $170.47 |
| Q2 2018 | -8,757 | Reduce 34.68% | 16,497 | $184.58 |
| Q3 2018 | -16,497 | Sold Out | 16,497 | $0.00 |
| Q1 2019 | +38,293 | New Buy | 38,293 | $189.98 |
| Q2 2019 | -36,014 | Reduce 94.05% | 2,279 | $184.29 |
| Q3 2019 | -2,279 | Sold Out | 2,279 | $0.00 |
| Q4 2019 | +11,294 | New Buy | 11,294 | $241.10 |
| Q1 2020 | -507 | Reduce 4.49% | 10,787 | $202.74 |
| Q2 2020 | -3,364 | Reduce 31.19% | 7,423 | $235.89 |
| Q3 2020 | -7,423 | Sold Out | 7,423 | $0.00 |
| Q2 2021 | +5,862 | New Buy | 5,862 | $243.77 |
| Q3 2021 | -1,371 | Reduce 23.39% | 4,491 | $212.65 |
| Q4 2021 | -4,491 | Sold Out | 4,491 | $0.00 |
| Q1 2022 | +4,619 | New Buy | 4,619 | $241.83 |
| Q2 2022 | +7,160 | Add 155.01% | 11,779 | $243.31 |
| Q3 2022 | -11,779 | Sold Out | 11,779 | $0.00 |
| Q1 2023 | +97,393 | New Buy | 97,393 | $0.24 |
| Q2 2023 | -78,777 | Reduce 80.89% | 18,616 | $222.02 |
| Q3 2023 | -18,616 | Sold Out | 18,616 | $0.00 |
| Q1 2024 | +164,400 | New Buy | 164,400 | $284.32 |
| Q2 2024 | -164,400 | Sold Out | 164,400 | $0.00 |
| Q4 2024 | +59,169 | New Buy | 59,169 | $260.64 |
| Q1 2025 | -8,814 | Reduce 14.90% | 50,355 | $311.55 |
| Q2 2025 | +6,736 | Add 13.38% | 57,091 | $279.21 |
| Q3 2025 | +62,743 | Add 109.90% | 119,834 | $282.20 |
Paul Tudor Jones's Amgen Investment FAQs
Paul Tudor Jones first purchased Amgen Inc. (AMGN) in Q2 2013, acquiring 6,300 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Paul Tudor Jones has held Amgen Inc. (AMGN) for 50 quarters since Q2 2013. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Paul Tudor Jones's largest addition to Amgen Inc. (AMGN) was in Q1 2024, adding 164,400 shares worth $46.74 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Paul Tudor Jones's firm, Tudor Investment Corp Et Al, owns 119,834 shares of Amgen Inc. (AMGN), valued at approximately $33.82 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, Amgen Inc. (AMGN) represents approximately 0.06% of Paul Tudor Jones's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Paul Tudor Jones's peak holding in Amgen Inc. (AMGN) was 164,400 shares, as reported at the end of Q1 2024. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.